Michele L. Nassin

Also affiliated with Tris Pharma (United States)

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 1 paper. Top paper: “Efficacy of post‐induction therapy for high‐risk neuroblastoma patients with end‐induction residual disease”.

Efficacy of post‐induction therapy for high‐risk neuroblastoma patients with end‐induction residual disease

Cancer(2022)10.1002/cncr.34263

N/A

0DataRank · unranked

13 citations

Mark A. Applebaum, Theodore Karrison, Akosua Y. Oppong, Cindy Yuan, Katherine R. Berg +14 more